UNSPSC 51286803: Nitroxoline

This classification denotes a quinolone antibiotic with the molecular formula C9H6N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A8M33244M6, chemically known as 8-quinolinol, 5-nitro- but more generally known as nitroxoline, which bears US NIH Compound Identifier 19910. European Medicines Agency schedules Nitroxoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09331MIG. The term NITROXOLINE is an International Non-Proprietary Name.

The World Health Organization schedules nitroxoline in its Anatomical Therapeutic Chemical (ATC) Classification. NITROXOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: OC1C2NCCCC2C([N](=O)O)CC1.

UNSPSC 51286803 Nitroxoline is a Commodity code nominally naming a single pharmaceutical product, but recent state and local solicitations tagged under this code actually cover a much broader spectrum of pharmaceutical procurement — generic multi-source drugs, over-the-counter products, naloxone and emergency medical supplies, and direct-to-manufacturer prescription fulfillment programs. The mismatch between the code's narrow name and the actual work being bought reflects how state and local procurement offices use UNSPSC taxonomy to tag pharmacy and medical supply acquisitions without strict adherence to individual product codes. State and local buyers under this code range from county health departments and city fire-rescue divisions to state health agencies and regional cooperative purchasing alliances, with issuing bodies including Seminole County, Florida; the City of Tampa; the Texas Health and Human Services Commission; and the Minnesota Department of Administration on behalf of the multistate MMCAP alliance.

Recent activity spans Florida, Texas, Minnesota, and Oregon, with the most substantive near-term opportunity being the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, which seeks manufacturers to supply through three authorized wholesalers with awards effective July 1, 2026. The City of Tampa issued an IFB (26P00145) for medical and first aid supplies for its Fire Department Rescue Division on March 25, 2026, with an estimated contract value of $700,000 and a Small Local Business Enterprise set-aside with a 5% bid discount. Seminole County, Florida, is procuring naloxone and drug deactivation systems through IFB 60459723LAS with a response deadline of July 26, 2023 (note: this date appears historically placed in the source despite the posting date of June 30, 2026). The Texas HHS Commission issued an exploratory RFI (HHS0017013) in April 2026 to gather vendor information about direct-to-manufacturer prescription programs before developing formal procurement specifications. Cooperative purchasing vehicles and multi-award structures are common in this code's recent activity, reflecting how state and local health systems consolidate pharmaceutical sourcing across jurisdictions.